Professor Kazeem Adeola Oshikoya

M.B; B.S, MSc, PhD

Orcid
Linkedin

kazeem.oshikoya@lasucom.edu.ng

Academic Background, Trainings, Skills, Positions, Teaching, Achievements (in Summary).

Dr. Kazeem Adeola Oshikoya is an Associate Professor of Pediatric Clinical Pharmacology at the Lagos State University College of Medicine in Ikeja, Lagos, Nigeria and currently the Acting Head, Department of Pharmacology, Therapeutics and Toxicology. He is also an Associate Editor, West African Journal of Pharmacology and Drug Research. He obtained his undergraduate degree in Medicine and Surgery (1996) and Master of Science Degree in Pharmacology (2000) from the College of Medicine, University of Lagos, Nigeria. He received his Ph.D. in Pediatric Clinical Pharmacology from the University of Nottingham, United Kingdom, in 2014 under the supervision of Professor Imti Choonara and Dr. Helen Sammons. Kazeem has academic career spanning two decades and over the years he has published extensively in the field of Pharmacovigilance, Pharmacoepidemiology, Medical Education on Rational Medicine Use, Drug Metabolism, and Pharmacogenomics. He has made over 80 scholarly contributions, including nearly 50 peer-reviewed research papers (h-index = 25; i10-index = 46; May 2016). He is a recipient of the Late Otunba Adeniran Ogunsanya Scholarship for undergraduate study at the College of Medicine, University of Lagos, Nigeria (1990-1996); Lagos State Government Foreign Scholarship for postgraduate study in the United Kingdom (2008-2012); Travel Scholarship by the organizers of ICIUM 2011 to attend the 3rd International Conference for Improving use of Medicines at Antalya, Turkey in November 14-18 (2011); Partial Scholarship from the International Society for Pharmacoepidemiology to attend the ICPE meeting in Barcelona, Spain, 23-25 August (2012); IUPHAR-Education Bursary Scholarship to attend the EACPT summer school of Education in Amsterdam, the Netherlands, 23-25 August (2012); and Therapeutic Editor Fellowship Training 2014, Melbourne, Australia, 1-14 June (2014). He belongs to many academic societies in both Nigeria and internationally, including the West African Society for Pharmacology (WASP-SOAP), International Society for Pharmacoepidemiology (ISPE), ISPE-Africa Group, and American Society for Clinical Pharmacology and Therapeutics (ASCPT).

Research Interests/Specialisations

Pharmacovigilance, pharmacoepidemiology, drug metabolism, pharmacogenetics, drug-drug interactions, medication errors. Specializes in pediatric clinical pharmacology

Publications

1. ROSSOW, M. Katelyn; OSHIKOYA, A. Kazeem; AKA, T. Ida; MAXWELL-HORN, C. Angela; RODEN, M. Dan M; VAN DRIEST, L. Sara, (2020),
Evidence for Pharmacogenomic Effects on Risperidone Outcomes in Pediatrics”, Journal of Developmental & Behavioral Pediatrics, Vol. 00,Issue 1,Pp. 1-8 ,
DOI: 10.1097/DBP.0000000000000883

Evidence for Pharmacogenomic Effects on Risperidone Outcomes in Pediatrics”, Journal of Developmental & Behavioral Pediatrics, Vol. 00,Issue 1,Pp. 1-8 , DOI: 10.1097/DBP.0000000000000883

2. OSHIKOYA, Adeola Kazeem; OGUNYINKA, Abayomi Ibrahim; IMUZEI, Ese Shallom; GARBA, Ilah Bilikisu; JIYA, Nma Mohammed, (2020),
A Retrospective Audit of Pharmacologic and Non-Pharmacologic Management of Childhood Acute Asthma Exacerbation at Usmanu Danfodiyo University Teaching Hospital, Sokoto: Adherence to Global Treatment Guidelines”, Frontier Pharmacology, Vol. 11,Issue 1,Pp. 1-13 ,
DOI: Doi: 10.3389/fphar.2020.531894

A Retrospective Audit of Pharmacologic and Non-Pharmacologic Management of Childhood Acute Asthma Exacerbation at Usmanu Danfodiyo University Teaching Hospital, Sokoto: Adherence to Global Treatment Guidelines”, Frontier Pharmacology, Vol. 11,Issue 1,Pp. 1-13 ,

DOI: Doi: 10.3389/fphar.2020.531894

3. OSHIKOYA, Adeola Kazeem; OGUNYINKA, Abayomi Ibrahim; OGAR, Kunak Comfort, Abiodun ABIOLA Abiodun; ALI, Ibrahim; OREAGBA, Adekunle Ibrahim, (2020)
Severe Cutaneous Adverse Drug Reactions Manifesting as Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reported to the National Pharmacovigilance Center in Nigeria: A Database Review from 2004 to 2017”, Therapeutic Advances in Drug Safety, Vol. 11,Issue ,Pp. 1-18 ,
DOI: 10.1177/2042098620905998

Severe Cutaneous Adverse Drug Reactions Manifesting as Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reported to the National Pharmacovigilance Center in Nigeria: A Database Review from 2004 to 2017”, Therapeutic Advances in Drug Safety, Vol. 11,Issue ,Pp. 1-18 ,

DOI: 10.1177/2042098620905998

4. OSHIKOYA A. Kazeem, WHARTON T. Gerold, AVANT Debbie, Van Driest L. Sara, FENN NE, LADIERI Allison, DOE Edwin, SOOD Beena, TAKETOMO Carol , LIEU P, YEN L, McMAHON W. Ann, (2019),
Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review”, Pediatric Drugs, Vol. 21,Issue 1,Pp. 47-58 ,
DOI: 10.1007/s40272-018-0318-9

Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review”, Pediatric Drugs, Vol. 21,Issue 1,Pp. 47-58 , DOI: 10.1007/s40272-018-0318-9

5. OFFOR Ifeanyichukwu, AWODELE Olufunsho, OSHIKOYA A. Kazeem, (2019),
Drug-related Teratogenic and Pathologic Causes of Birth Defects in a Tertiary Hospital in Southwestern Nigeria”, Pharmacology Research and Perspectives, Vol. 7,Issue 1,Pp. 452-460 ,
DOI: 10.1002/prp2.452

Drug-related Teratogenic and Pathologic Causes of Birth Defects in a Tertiary Hospital in Southwestern Nigeria”, Pharmacology Research and Perspectives, Vol. 7,Issue 1,Pp. 452-460 , DOI: 10.1002/prp2.452

6. OOGUNYINKA A. Ibrahim, OSHIKOYA A. Kazeem, OLOWO-OKERE Ahmed. LUKONG C. Suiyel, ADAMAIGBO Comfort, ADEBAYO A. Adekunle, (2019),
Appropriateness of Postoperative Analgesic Doses Among Pediatric Surgical Patients in a Teaching Hospital in Northwest Nigeria”, Drug Therapy and Perspectives, Vol. 35,Issue 3,Pp. 135-144 ,
DOI: 10.1007/s40267-019-00604-0

Appropriateness of Postoperative Analgesic Doses Among Pediatric Surgical Patients in a Teaching Hospital in Northwest Nigeria”, Drug Therapy and Perspectives, Vol. 35,Issue 3,Pp. 135-144 ,

DOI: 10.1007/s40267-019-00604-0

7. OSHIKOYA A. Kazeem, NEELY M. Katelyn, CARROLL Robert, AKA T. Ida, MAXWELL-HORN Angela, RODEN M. Dan, Van Driest L. Sara, (2019),
CYP2D6 Genotype and Adverse Events to Risperidone in Children and Adolescents”, Pediatric Research, Vol. 85,Issue 5,Pp. 602-606 ,
DOI: 10.1038/s41390-019-0305-z

CYP2D6 Genotype and Adverse Events to Risperidone in Children and Adolescents”, Pediatric Research, Vol. 85,Issue 5,Pp. 602-606 , DOI: 10.1038/s41390-019-0305-z

8. OSHIKOYA A.Kazeem, CARROLL Robert, IKA T. Ada, RODEN M. Dan, VAN DRIEST L. Sara, (2019),
Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study”, Drugs Real World Outcomes, Vol. 6,Issue 2,Pp. 4-10 ,
DOI: https://dx.doi.org/10.1007/s40801-017-0124-7

Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study”, Drugs Real World Outcomes, Vol. 6,Issue 2,Pp. 4-10 ,

DOI: https://dx.doi.org/10.1007/s40801-017-0124-7

9. OSHIKOYA A. Kazeem, OGUNYINKA A. Ibrahim, GODMAN Brian, (2019),
Off-label Use of Pentazocine and the Associated Adverse Events Among Pediatric Surgical Patients in a Tertiary Hospital in Northern Nigeria: A Retrospective Chart Review”, Current Medical Research and Opinion, Vol. 3,Issue 2,Pp. 1-10 .

Off-label Use of Pentazocine and the Associated Adverse Events Among Pediatric Surgical Patients in a Tertiary Hospital in Northern Nigeria: A Retrospective Chart Review”, Current Medical Research and Opinion, Vol. 3,Issue 2,Pp. 1-10 .

10. OREAGBA A. Ibrahim, USMAN O. Sikiru, OSHIKOYA A. Kazeem, AKINYEDE Akinwumi, AGBAJE Esther, OPANUGA Oluranti, AKANMU Sulaiman, (2019),
Clinically Significant Drug-Drug Interaction in a Large Antiretroviral Treatment Centre in Lagos, Nigeria”, Journal of Population Therapeutics and Clinical Pharmacology, Vol. 26,Issue 1,Pp. 1-19 ,
DOI: https://doi.org/10.22374/1710-6222.26.1.1

Clinically Significant Drug-Drug Interaction in a Large Antiretroviral Treatment Centre in Lagos, Nigeria”, Journal of Population Therapeutics and Clinical Pharmacology, Vol. 26,Issue 1,Pp. 1-19 ,

DOI: https://doi.org/10.22374/1710-6222.26.1.1

Professor Kazeem Adeola Oshikoya